(Press-News.org) New Rochelle, NY, July 6, 2011—A policy specialist and a healthcare economist both say that the oft-quoted cost of $1.32 billion to bring a new drug to market does not hold up to close scrutiny, reports Genetic Engineering & Biotechnology News (GEN). The researchers emphasize that available cost data cannot be trusted because the numbers are subject to numerous internal and external sources of variability, according to the July issue of GEN (http://www.genengnews.com/gen-articles/drug-r-d-costs-questioned/3707).
"With heated discussions still taking place over healthcare reform and a regulatory environment increasingly focused on safety, the GEN point of view piece should serve as an important article for multiple discussions on new drug R&D and commercialization costs," says John Sterling, Editor in Chief of GEN. "We hope that the article leads to an informative debate on this crucial issue of new drug research and development costs."
Donald W. Light, Ph.D., a professor at the University of Medicine and Dentistry of New Jersey and the Lokey visiting professor in human biology at Stanford University, and Rebecca Warburton, Ph.D., an associate professor at the University of Victoria (British Columbia), claim that pharmaceutical firms list their R&D costs as high as possible to garner greater prices for their products. Yet, continue the article's authors, a number of independent review groups report that 85% of new drugs exhibit few if any advantages over existing drugs.
Noting that the "R" in R&D is basically unknown and highly variable, Drs. Light and Warburton estimate that the median development ("D") cost for a new drug in 2000 was about $60 million (ranging from $13 million to $203 million depending on the type of drug) while the median D cost in 2006 was approximately $98 million (ranging from $21 million to $333 million).
For a copy of the July issue of GEN, please call (914) 740-2122, or email: ebicovny@liebertpub.com
Genetic Engineering & Biotechnology News (GEN, www.genengnews.com) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, such as news and analysis, podcasts, webinars, polls, videos, and application notes. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.
INFORMATION:
GEN point of view article questions reported costs of drug R&D
2011-07-07
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Simpsonville Hotel Provides a Special Rate to Fans Attending Miranda Lambert at Charter Amphitheatre
2011-07-07
Holiday Inn Express Hotel Simpsonville provides a special rate for guests attending Miranda Lambert on July 16, 2011. The show will take place at 7:30pm in Charter Amphitheatre at Heritage Park. Special guests include Josh Kelley & Ashton Shepherd. Travelers attending any concert at Charter Amphitheatre can select the "Greenville Arena Discount" when booking at the Holiday Inn Express Simpsonville to receive a 10% discount. Some restrictions may apply.
Miranda Lambert is an American country music singer who gained fame as a finalist on the 2003 season ...
John Theurer Cancer Center BMT researchers highlight the importance of social support
2011-07-07
Hackensack, NJ (June 29, 2011) – Researchers at the John Theurer Cancer Center recently published a study delineating the connection of social support to distress after stem cell transplants. Scott Rowley, M.D., Chief, Blood & Marrow Stem Cell Transplantation Program, the John Theurer Cancer Center at Hackensack University Medical Center contributed to the study which was led by Larissa E. Labay from Mt. Sinai. The study was published in the Journal of Consulting and Clinical Psychology, a peer-reviewed publication produced by the American Psychological Association.
The ...
London bombing memories explored
2011-07-07
Los Angeles, CA (July 7th, 2011) - Six years on from the devastating 7/7 London bombings and in the wake of the inquest into the attacks, a special issue of the journal Memory Studies, published by SAGE, explores new research into our collective memories of this tragic event.
"The London attacks make for a particularly compelling case study of contemporary remembrance and commemoration," say authors of the lead editorial, Matthew Allen and Annie Bryan. "Significantly, it would seem that a wider social project of remembering the bombings is at odds with the inquest's ...
Guoman's Charing Cross Hotel Launches the New Look Eleanor's Bar
2011-07-07
Guoman's Charing Cross Hotel has announced the launch Eleanor's bar.
The grand Charing Cross Hotel has undergone refurbishment to create a new look destination bar; Eleanor's, a sophisticated space designed to provide a luxurious oasis from the buzzing hub of The Strand and Trafalgar Square.
The charming four-star hotel is literally situated at the very centre of London, making it the perfect location for meeting friends, enjoying a leisurely cocktail after work or pre-theatre drinks. The bar's beverage offering has also been revamped and Eleanor's tempting new menu ...
Mercury vapor released from broken compact fluorescent light bulbs can exceed safe exposure levels
2011-07-07
New Rochelle, NY, July, 6, 2011—Once broken, a compact fluorescent light bulb continuously releases mercury vapor into the air for weeks to months, and the total amount can exceed safe human exposure levels in a poorly ventilated room, according to study results reported in Environmental Engineering Science, a peer-reviewed online only journal published monthly by Mary Ann Liebert, Inc. (www.liebertpub.com). The article is available free online at www.liebertpub.com/ees
The amount of liquid mercury (Hg) that leaches from a broken compact fluorescent lamp (CFL) is lower ...
The National Trust Invites Public to Choose Sheep for Farm Experiment
2011-07-07
The National Trust has revealed that members of the public will decide which flock of sheep will be bought by a working, commercial farm as part of the MyFarm* experiment which aims to re-connect people with the day-to-day realities of farming.
Under the banner 'You choose the Ewes', subscribers signed up for the experiment will be asked to choose between buying 100 commercial or rare breed sheep**, to expand the current flock.
They will be asked to consider the financial consequences, the implications for rare-breed bloodline and environmental impacts, as well as ...
You are what you tweet: Tracking public health trends with Twitter
2011-07-07
Twitter allows millions of social media fans to comment in 140 characters or less on just about anything: an actor's outlandish behavior, an earthquake's tragic toll or the great taste of a grilled cheese sandwich.
But by sifting through this busy flood of banter, is it possible to also track important public health trends? Two Johns Hopkins University computer scientists would respond with a one-word tweet: "Yes!"
Mark Dredze and Michael J. Paul fed 2 billion public tweets posted between May 2009 and October 2010 into computers, then used software to filter out the ...
Aer Lingus Announces One Million Seat Sale
2011-07-07
Aer Lingus has announced a massive seat sale across its entire network.
The one million seat sale will see one million great value seats to the UK, Continental Europe and the USA, which went on sale at the start of July 2011.
The sale will see one way fares starting from EUR19.99 on UK routes, EUR29.99 on European routes and from EUR219 each way to the USA, inclusive of taxes and charges.
Aer Lingus director of communications, Declan Kearney said: "It's our 75th anniversary year and we're delighted to be giving something back to our loyal customers. We've ...
Can in-hospital falls really be prevented?
2011-07-07
ROSEMONT, Ill.–While falls are a common cause of injury, particularly in older, hospitalized patients, some may not be as preventable as once thought. According to a new literature review published in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), many of the risks that frequently cause falls are not adequately addressed with the fall prevention initiatives used in healthcare facilities.
Falls are the leading cause of fatal and nonfatal injuries to older people in the United States. Each year, more than 11 million people older than 65 years of age ...
Microalgae could be Texas' next big cash crop
2011-07-07
CORPUS CHRISTI – Just as corn and peanuts stunned the world decades ago with their then-newly discovered multi-beneficial uses and applications, Texas AgriLife Research scientists in Corpus Christi think microalgae holds even more promise.
"It's a huge, untapped source of fuel, food, feed, pharmaceuticals and even pollution-busters," said Dr. Carlos Fernandez, a crop physiologist at the Texas AgriLife Research and Extension Center at Corpus Christi who is studying the physiological responses of microalgae to the environment.
There are an estimated 200,000 to 800,000 ...